Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes

The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues

(2018) Nong Yang et al.   BMC CANCER

Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients

(2018) Emil Christensen et al.   Scientific Reports

Mutation load estimation model as a predictor of the response to cancer immunotherapy

(2018) Guan-Yi Lyu et al.   npj Genomic Medicine

Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma

(2017) Andrea B. Moffitt et al.   JOURNAL OF CLINICAL ONCOLOGY

Direct detection of early-stage cancers using circulating tumor DNA

(2017) Jillian Phallen et al.   Science Translational Medicine

Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors

(2017) David Quigley et al.   Cancer Discovery

Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials

(2017) Ronald L Van Heertum et al.   Drug Design Development and Therapy

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

(2017) Zachary R. Chalmers et al.   Genome Medicine

Precision Medicine for Diffuse Large B-cell Lymphoma

(2016) M. S. Lim et al.   CLINICAL CANCER RESEARCH

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

(2016) Geoffrey T Gibney et al.   LANCET ONCOLOGY

Integrated digital error suppression for improved detection of circulating tumor DNA

(2016) Aaron M Newman et al.   NATURE BIOTECHNOLOGY

COSMIC: somatic cancer genetics at high-resolution

(2016) Simon A. Forbes et al.   NUCLEIC ACIDS RESEARCH

Evaluating the evaluation of cancer driver genes

(2016) Collin J. Tokheim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations

(2016) Chenglin Wu et al.   Oncotarget

The minimal amount of starting DNA for Agilent’s hybrid capture-based targeted massively parallel sequencing

(2016) Jongsuk Chung et al.   Scientific Reports

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

(2015) D. M. Kurtz et al.   BLOOD

Racial differences in three major NHL subtypes: Descriptive epidemiology

(2015) Yang Li et al.   Cancer Epidemiology

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

(2015) Donavan T. Cheng et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

(2015) Alessandro Pastore et al.   LANCET ONCOLOGY

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

(2015) Mark Roschewski et al.   LANCET ONCOLOGY

Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice

(2015) Luís Felipe Campesato et al.   Oncotarget

The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature

(2014) R. Manso et al.   BLOOD

Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers

(2014) P. D. Garcia et al.   CLINICAL CANCER RESEARCH

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

(2014) Mamiko Sakata-Yanagimoto et al.   NATURE GENETICS

Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma

(2013) Junshik Hong et al.   ACTA HAEMATOLOGICA

Lessons from next-generation sequencing analysis in hematological malignancies

(2013) E Braggio et al.   Blood Cancer Journal

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

(2012) R. A. Cairns et al.   BLOOD

Non-Hodgkin lymphoma

(2012) Kate R Shankland et al.   LANCET